{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:06:56Z","timestamp":1792487216621,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd014585","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000}}],"reference-count":79,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014585.pub2","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T07:14:02Z","timestamp":1746688442000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug-induced ulcers and dyspepsia"],"prefix":"10.1002","volume":"2025","author":[{"given":"Luis","family":"Garegnani","sequence":"additional","affiliation":[{"name":"Cochrane Associate Centre; Universidad Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Oltra","sequence":"additional","affiliation":[{"name":"Cochrane Associate Centre; Universidad Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Andrea","family":"Burgos","sequence":"additional","affiliation":[{"name":"Cochrane Associate Centre; Universidad Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Ivaldi","sequence":"additional","affiliation":[{"name":"Cochrane Associate Centre; Universidad Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia B","family":"Varela","sequence":"additional","affiliation":[{"name":"Cochrane Associate Centre; Universidad Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samanta","family":"D\u00edaz Menai","sequence":"additional","affiliation":[{"name":"Cochrane Associate Centre; Universidad Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Puga-Tejada","sequence":"additional","affiliation":[{"name":"Instituto Ecuatoriano de Enfermedades Digestivas; Guayaquil Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Micaela","family":"Escobar Liquitay","sequence":"additional","affiliation":[{"name":"Cochrane Associate Centre; Universidad Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan VA","family":"Franco","sequence":"additional","affiliation":[{"name":"Institute of General Practice; Medical Faculty of the Heinrich-Heine-University D\u00fcsseldorf; D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD014585.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/03007995.2017.1281110","article-title":"Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review","volume":"33","author":"Yang","year":"2017","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/dhps.s4334","article-title":"Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors","volume":"1","author":"Rostom","year":"2009","journal-title":"Drug, Healthcare and Patient Safety"},{"issue":"7365","key":"10.1002\/14651858.CD014585.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1136\/bmj.325.7365.624","article-title":"Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs","volume":"325","author":"Mamdani","year":"2002","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"6","key":"10.1002\/14651858.CD014585.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.farma.2010.10.007","article-title":"Trends in gastrointestinal bleeding in the Region of Valencia (2000\u20132005). Relationship to sales of nonsteroidal anti-inflammatory drugs and acid suppression medication","volume":"35","author":"Peir\u00f3 Moreno","year":"2011","journal-title":"Farmacia Hospitalaria"},{"issue":"4","key":"10.1002\/14651858.CD014585.pub2-BIB0005|cit5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002296","article-title":"Prevention of NSAID-induced gastroduodenal ulcers","author":"Rostom","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD014585.pub2-BIB0006|cit6","first-page":"24","article-title":"Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults","volume":"18","author":"Marcum","year":"2010","journal-title":"Annals of Long-Term Care"},{"issue":"14","key":"10.1002\/14651858.CD014585.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2174\/1381612053764904","article-title":"Gastrointestinal effects of selective and non-selective non-steroidal anti-inflammatory drugs","volume":"11","author":"Akarca","year":"2005","journal-title":"Current Pharmaceutical Design"},{"issue":"1","key":"10.1002\/14651858.CD014585.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00264-009-0886-y","article-title":"Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials","volume":"35","author":"Xue","year":"2011","journal-title":"International Orthopaedics"},{"issue":"3","key":"10.1002\/14651858.CD014585.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/MCG.0b013e318241b335","article-title":"Dyspepsia: organic versus functional","volume":"46","author":"Oustamanolakis","year":"2012","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD014585.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ueg2.12061","article-title":"United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia","volume":"9","author":"Wauters","year":"2021","journal-title":"United European Gastroenterology Journal"},{"issue":"3","key":"10.1002\/14651858.CD014585.pub2-BIB0011|cit11","first-page":"219","article-title":"Peptic ulcer disease and Helicobacter pylori infection","volume":"115","author":"Narayanan","year":"2018","journal-title":"Missouri Medicine"},{"issue":"8","key":"10.1002\/14651858.CD014585.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1111\/j.1572-0241.2002.05905.x","article-title":"Do NSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsia definitions","volume":"97","author":"Straus","year":"2002","journal-title":"American Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD014585.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S2468-1253(18)30003-7","article-title":"Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study","volume":"3","author":"Aziz","year":"2018","journal-title":"Lancet, Gastroenterology & Hepatology"},{"issue":"7","key":"10.1002\/14651858.CD014585.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1136\/gutjnl-2014-307843","article-title":"Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis","volume":"64","author":"Ford","year":"2015","journal-title":"Gut"},{"issue":"9","key":"10.1002\/14651858.CD014585.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1365-2036.2009.03960.x","article-title":"Systematic review: the global incidence and prevalence of peptic ulcer disease","volume":"29","author":"Sung","year":"2009","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD014585.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1365-2036.2012.05118.x","article-title":"The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010","volume":"36","author":"Musumba","year":"2012","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD014585.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ajg.2009.115","article-title":"Guidelines for prevention of NSAID-related ulcer complications","volume":"104","author":"Lanza","year":"2009","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD014585.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ajg.2011.2","article-title":"Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression","volume":"106","author":"S\u00e1nchez-Delgado","year":"2011","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD014585.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.giec.2015.02.010","article-title":"Epidemiology and risk factors for upper gastrointestinal bleeding","volume":"25","author":"Tielleman","year":"2015","journal-title":"Gastrointestinal Endoscopy Clinics of North America"},{"issue":"2","key":"10.1002\/14651858.CD014585.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bpg.2009.11.005","article-title":"Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract","volume":"24","author":"Sostres","year":"2010","journal-title":"Best Practice & Research Clinical Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD014585.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.23736\/S0026-4806.18.05705-1","article-title":"The appropriate use of proton-pump inhibitors","volume":"109","author":"Savarino","year":"2018","journal-title":"Minerva Medica"},{"issue":"20","key":"10.1002\/14651858.CD014585.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.3390\/ijms20205203","article-title":"Adverse effects of proton pump inhibitors \u2013 evidence and plausibility","volume":"20","author":"Fossmark","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10.1002\/14651858.CD014585.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/14740338.2019.1664470","article-title":"Proton pump inhibitors, adverse events and increased risk of mortality","volume":"18","author":"Lanas-Gimeno","year":"2019","journal-title":"Expert Opinion on Drug Safety"},{"issue":"1","key":"10.1002\/14651858.CD014585.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5009\/gnl15502","article-title":"25 years of proton pump inhibitors: a comprehensive review","volume":"11","author":"Strand","year":"2017","journal-title":"Gut and Liver"},{"issue":"3","key":"10.1002\/14651858.CD014585.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1053\/j.gastro.2019.07.039","article-title":"Safety and complications of long-term proton pump inhibitor therapy: getting closer to the truth","volume":"157","author":"Corley","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0026|cit26","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological Expectations of Cochrane Intervention Reviews https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"5","key":"10.1002\/14651858.CD014585.pub2-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014585","article-title":"Proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug-induced ulcers and dyspepsia","author":"Garegnani","year":"2022","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0029|cit29","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"issue":"4","key":"10.1002\/14651858.CD014585.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1365-2036.2005.02572.x","article-title":"Validation of the gastrointestinal symptom score for the assessment of symptoms in patients with functional dyspepsia","volume":"22","author":"Adam","year":"2005","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD014585.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/s0895-4356(00)00365-6","article-title":"SODA (Severity Of Dyspepsia Assessment): a new effective outcome measure for dyspepsia-related health","volume":"54","author":"Rabeneck","year":"2001","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD014585.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1023\/a:1005558204440","article-title":"Patient-based assessment in dyspepsia: development and validation of Dyspepsia Symptom Severity Index (DSSI)","volume":"45","author":"Leidy","year":"2000","journal-title":"Digestive Diseases and Sciences"},{"issue":"2","key":"10.1002\/14651858.CD014585.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2036.1999.00445.x","article-title":"Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index","volume":"13","author":"Talley","year":"1999","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD014585.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1097\/00042737-199610000-00006","article-title":"The Glasgow Dyspepsia Severity Score \u2013 a tool for the global measurement of dyspepsia","volume":"8","author":"El-Omar","year":"1996","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD014585.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medical Care"},{"issue":"10","key":"10.1002\/14651858.CD014585.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Quality of Life Research"},{"issue":"5","key":"10.1002\/14651858.CD014585.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s10620-017-4499-9","article-title":"Responsiveness to change and minimally important differences of the Patient-Reported Outcomes Measurement Information System Gastrointestinal Symptoms scales","volume":"62","author":"Khanna","year":"2017","journal-title":"Digestive Diseases and Sciences"},{"issue":"12","key":"10.1002\/14651858.CD014585.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence \u2013 imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0039|cit39","unstructured":"Covidence Veritas Health Innovation 2023"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0040|cit40","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"7109","key":"10.1002\/14651858.CD014585.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0042|cit42","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook\/archive\/v6.2"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis Without Meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"7414","key":"10.1002\/14651858.CD014585.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","article-title":"The GRADE Working Group clarifies the construct of certainty of evidence","volume":"87","author":"Hultcrantz","year":"2017","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0046|cit46","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2023"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD014585.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2036.2006.03210.x","article-title":"Efficacy of esomeprazole for resolution of symptoms of heartburn and acid regurgitation in continuous users of non-steroidal anti-inflammatory drugs","volume":"25","author":"Hawkey","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD014585.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1186\/ar2124","article-title":"Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies","volume":"9","author":"Hawkey","year":"2007","journal-title":"Arthritis Research & Therapy"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0050|cit50","unstructured":"Esomeprazole for relief of upper gastrointestinal symptoms associated with continuous use of nsaids https:\/\/clinicaltrials.gov\/study\/NCT00241527"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0051|cit51","unstructured":"Esomeprazole for prevention of upper gastrointestinal symptoms associated with continuous use of nsaids https:\/\/clinicaltrials.gov\/study\/NCT00241553"},{"issue":"5","key":"10.1002\/14651858.CD014585.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/j.1572-0241.2005.41465.x","article-title":"Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors","volume":"100","author":"Hawkey","year":"2005","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0053|cit53","unstructured":"Prevention of gastric ulcers https:\/\/clinicaltrials.gov\/study\/NCT00629512"},{"issue":"4","key":"10.1002\/14651858.CD014585.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1572-0241.2006.00499.x","article-title":"Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors","volume":"101","author":"Scheiman","year":"2006","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD014585.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/01.ebg.0000211619.00456.6c","article-title":"Preventing GI toxicity from NSAIDS \u2013 a PPI for everyone?","volume":"7","author":"Eisen","year":"2006","journal-title":"Evidence-Based Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD014585.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ahj.2014.05.017","article-title":"PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies","volume":"168","author":"Whellan","year":"2014","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1038\/ajg.2013.261","article-title":"Long-term safety of PA32540, a coordinated delivery tablet of 325 mg of enteric-coated aspirin and 40 mg of immediate-release omeprazole in secondary cardiovascular patients at risk for gastrointestinal events","volume":"108","author":"Goldstein","year":"2013","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD014585.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"A252","DOI":"10.1177\/2050640613502900","article-title":"Upper gastrointestinal event reduction and cardiovascular safety of antiplatelet therapy with PA32540, a tablet with enteric-coated aspirin and immediate-release omeprazole: results of two 6-month, phase 3 studies","volume":"1","author":"Lanas","year":"2013","journal-title":"United European Gastroenterology Journal"},{"issue":"3","key":"10.1002\/14651858.CD014585.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/s1590-8658(00)80821-x","article-title":"Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study","volume":"32","author":"Bianchi Porro","year":"2000","journal-title":"Digestive and Liver Disease"},{"issue":"9573","key":"10.1002\/14651858.CD014585.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/S0140-6736(07)60749-1","article-title":"Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial","volume":"369","author":"Chan","year":"2007","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0061|cit61","unstructured":"Preventing recurrent ulcer bleeding in arthritis patients using esomeprazole plus celecoxib https:\/\/clinicaltrials.gov\/study\/NCT00365313"},{"issue":"2","key":"10.1002\/14651858.CD014585.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1046\/j.1365-2036.1998.00288.x","article-title":"Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users","volume":"12","author":"Cullen","year":"1998","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD014585.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3109\/00365529609010347","article-title":"Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study","volume":"31","author":"Ekstr\u00f6m","year":"1996","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"10","key":"10.1002\/14651858.CD014585.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.clinthera.2004.10.002","article-title":"Ulcer recurrence in high-risk patients receiving nonsteroidal anti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis","volume":"26","author":"Goldstein","year":"2004","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD014585.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/archinte.162.2.169","article-title":"Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole","volume":"162","author":"Graham","year":"2002","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD014585.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2036.2005.02477.x","article-title":"Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine","volume":"21","author":"Miyake","year":"2005","journal-title":"Alimentary Pharmacology and Therapeutics, Supplement"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1093\/eurheartj\/ehq289","article-title":"Esomeprazole 20 mg and 40 mg for 26 weeks reduces the frequency of upper GI symptoms in patients taking low-dose acetylsalicylic acid (ASA) for cardiovascular prevention: the OBERON trial","volume":"31","author":"Scheiman","year":"2010","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD014585.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/FJC.0b013e31827cb626","article-title":"Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trial","volume":"61","author":"Scheiman","year":"2013","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0069|cit69","unstructured":"Study of esomeprazole 20 mg or 40 mg vs placebo effectiveness on the occurrence of peptic ulcers in subjects on low dose acetylsalicylic acid (LDA) https:\/\/clinicaltrials.gov\/study\/NCT00441727"},{"key":"10.1002\/14651858.CD014585.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ijcard.2014.12.140","article-title":"Effect of esomeprazole on gastroduodenal erosions in patients at increased gastrointestinal risk treated with low-dose acetylsalicylic acid: a post-hoc analysis of the OBERON trial","volume":"182","author":"Scheiman","year":"2015","journal-title":"International Journal of Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD014585.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/hrt.2010.217547","article-title":"Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)","volume":"97","author":"Scheiman","year":"2011","journal-title":"Heart (British Cardiac Society)"},{"issue":"7","key":"10.1002\/14651858.CD014585.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1136\/gutjnl-2013-304722","article-title":"Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study","volume":"63","author":"Sugano","year":"2014","journal-title":"Gut"},{"issue":"10","key":"10.1002\/14651858.CD014585.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1111\/j.1572-0241.2008.01995.x","article-title":"Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin","volume":"103","author":"Yeomans","year":"2008","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD014585.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12876-023-02935-9","article-title":"Patient-reported outcome measures in functional dyspepsia: a systematic review and COSMIN analysis","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD014585.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJM199803123381105","article-title":"Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group","volume":"338","author":"Hawkey","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD014585.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1056\/NEJM199803123381104","article-title":"A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group","volume":"338","author":"Yeomans","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD014585.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S2468-1253(18)30037-2","article-title":"Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials","volume":"3","author":"Scally","year":"2018","journal-title":"Lancet. Gastroenterology & Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD014585.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2036.2008.03905.x","article-title":"Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks","volume":"29","author":"Rostom","year":"2009","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD014585.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"707","DOI":"10.5009\/gnl20246","article-title":"Clinical guidelines for drug-related peptic ulcer, 2020 revised edition","volume":"14","author":"Joo","year":"2020","journal-title":"Gut and Liver"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:18:53Z","timestamp":1788437933000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014585.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":79,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014585.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]}}}